Current Position:
Life Sciences Consultant at Putnam Associates
Doctoral Student:
2013 -2019
Education:
Ph.D., 2019, Harvard T.H. Chan School of Public Health, Biological Sciences in Public Health
M.S., 2013, Johns Hopkins Bloomberg School of Public Health
B.S., 2008, University of Rochester
Research Interest:
Erika is interested in examining the molecular mechanisms by which oncogenic signaling pathways alter cellular metabolism.
Publications:
Hoxhaj G, Hughes-Hallett J, Timson RC, Ilagan E, Yuan M, Asara JM, Ben-Sahra I, Manning BD. The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels. Cell Rep. 2017; 21(5):1331-1346. PMID: 29091770
Ilagan E, Manning BD. Emerging role of mTOR in the response to cancer therapeutics. Trends Cancer 2016; 2:241-251. PMID:27668290
Chung BM, Arutyunov A, Ilagan E, Yao N, Wills-Karp M, Coulombe PA. Regulation of C-X-C chemokine gene expression by keratin 17 and hnRNP K in skin tumor keratinocytes. J Cell Biol. 2015;208(5):613-27. PMID: 25713416